Solitary pulmonary nodule

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Lung nodule)
Jump to: navigation, search
Solitary pulmonary nodule
Classification and external resources
Malignant solitary pulmonary nodule: The patient is a 67 year old woman with a solitary pulmonary nodule on a recent chest x-ray. A retrospective review of prior chest x-rays suggests that this is nodule is of recent origin. This lesion was felt to be too peripheral for reliable bronchial wash findings.
DiseasesDB 29456
MedlinePlus 000071
eMedicine RADIO/782 
MeSH D003074

WikiDoc Resources for

Solitary pulmonary nodule

Articles

Most recent articles on Solitary pulmonary nodule

Most cited articles on Solitary pulmonary nodule

Review articles on Solitary pulmonary nodule

Articles on Solitary pulmonary nodule in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Solitary pulmonary nodule

Images of Solitary pulmonary nodule

Photos of Solitary pulmonary nodule

Podcasts & MP3s on Solitary pulmonary nodule

Videos on Solitary pulmonary nodule

Evidence Based Medicine

Cochrane Collaboration on Solitary pulmonary nodule

Bandolier on Solitary pulmonary nodule

TRIP on Solitary pulmonary nodule

Clinical Trials

Ongoing Trials on Solitary pulmonary nodule at Clinical Trials.gov

Trial results on Solitary pulmonary nodule

Clinical Trials on Solitary pulmonary nodule at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Solitary pulmonary nodule

NICE Guidance on Solitary pulmonary nodule

NHS PRODIGY Guidance

FDA on Solitary pulmonary nodule

CDC on Solitary pulmonary nodule

Books

Books on Solitary pulmonary nodule

News

Solitary pulmonary nodule in the news

Be alerted to news on Solitary pulmonary nodule

News trends on Solitary pulmonary nodule

Commentary

Blogs on Solitary pulmonary nodule

Definitions

Definitions of Solitary pulmonary nodule

Patient Resources / Community

Patient resources on Solitary pulmonary nodule

Discussion groups on Solitary pulmonary nodule

Patient Handouts on Solitary pulmonary nodule

Directions to Hospitals Treating Solitary pulmonary nodule

Risk calculators and risk factors for Solitary pulmonary nodule

Healthcare Provider Resources

Symptoms of Solitary pulmonary nodule

Causes & Risk Factors for Solitary pulmonary nodule

Diagnostic studies for Solitary pulmonary nodule

Treatment of Solitary pulmonary nodule

Continuing Medical Education (CME)

CME Programs on Solitary pulmonary nodule

International

Solitary pulmonary nodule en Espanol

Solitary pulmonary nodule en Francais

Businness

Solitary pulmonary nodule in the Marketplace

Patents on Solitary pulmonary nodule

Experimental / Informatics

List of terms related to Solitary pulmonary nodule

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

A solitary pulmonary nodule (SPN) or coin lesion is a mass in the lung smaller than 3 centimeters in diameter. It can be an incidental finding found in up to 0.2% of chest X-rays[1] and around 1% of CT scans.[1]

The nodule most commonly represents a benign tumor such as a granuloma or hamartoma, but in around 20% of cases it represents a malignant cancer,[1] especially in older adults and smokers. Conversely, 10 to 20% of patients with lung cancer are diagnosed in this way.[1] Thus, the possibility of cancer needs to be excluded through further radiological studies and interventions, possibly including surgical resection. The prognosis depends on the underlying condition.

Definition

A solitary pulmonary nodulus needs to be separated from larger lung tumors, smaller infiltrates or masses with other accompanying characteristics. An often used formal radiological definition is the following: a single lesion in the lung completely surrounded by lung parenchyma (functional tissue) with a diameter less than 3 cm and without associated pneumonia, atelectasis (lung collaps) or lymphadenopathies (swollen lymph nodes).[1][1]

Common Causes

Not every round spot on a radiological image is a coin lesion: it should not be confused with the projection of a structure of the chest wall or skin, such as a nipple, a healing rib fracture or electrocardiographic monitoring.

The most important cause to exclude is a form of lung cancer, including rare forms such as primary pulmonary lymphoma, carcinoid tumor and a solitary metastasis to the lung (common unrecognised primary tumor sites are melanomas, sarcomas or testicular cancer). Benign tumors in the lung include hamartomas and chondromas.

The most common benign coin lesion is a granuloma (inflammatory nodule), for example due to tuberculosis or a fungal infection. Other infectious causes include a pulmonary abscess, pneumonia (including Pneumocystis carinii pneumonia) or rarely Nocardial infection or worm infection (such as dirofilariasis or dog heartworm infestation). Lung nodules can also occur in immune disorders such as rheumatoid arthritis or Wegener's granulomatosis.

An SPN can be found to be an arteriovenous malformation, a hematoma or an infarction zone. It may also be caused by bronchial atresia, sequestration, an inhaled foreign body or pleural plaque.

Complete Differential Diagnosis

In alphabetical order [1]

Radiological features

Several features help to distinguish benign conditions from possible lung cancer. The first parameter is the size of the lesion: the smaller, the less risk for malignant cancer.[1] Benign causes tend to have a well defined border, whereas lobulated lesions or those with an irregular margin extending into the neighbouring tissue tend to be malignant.[1]

If there is a central cavity, then a thin wall points to a benign cause whereas a thick wall is associated with malignancy (especially 4mm or less versus 16mm or more).[1] In lung cancer, cavitation can represent central tumor necrosis (tissue death) or secondary abces formation. If the walls of an airway are visible (air bronchogram), bronchioloalveolar carcinoma is a possibility.

An SPN often contains calcifications. Certain patterns of calcification are reassuring, such as the popcorn-like appearance of hamartoma.[1] An SPN with a density below 15 Hounsfield units on computed tomography tends to be benign, whereas malignant tumors often measure more than 20 Hounsfield units. Fatty tissue inside hamartomas will have a strongly negative value on the Hounsfield scale.

The growth velocity of a lesion is also informative: very fast or very slow growing tumors are rarely malignant, in contrary to inflammatory or congenital conditions.[1] It is therefore important to retrieve previous imaging studies to see if a lesion was presented and how fast its volume is increasing. This is more difficult for nodules smaller than 1 centimeter. Moreover, the predictive value of stable lesion over a period of 2 years has been found to be rather low and unreliable.[1]

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology






Halo Sign

  • The halo sign refers to a zone of ground-glass attenuation surrounding a pulmonary nodule or mass on CT images.
  • The presence of a halo of ground-glass opacity or ground-glass attenuation is usually associated with hemorrhagic nodules.
  • In severely neutropenic patients, the halo sign is highly suggestive of infection by an angioinvasive fungus, most commonly Aspergillus.
  • Vascular invasion by this fungus results in thrombosis of small- to medium-sized vessels, which causes ischemic necrosis.
  • At pathologic examination, the nodules represent foci of infarction, and the halo of ground-glass attenuation results from alveolar hemorrhage.
  • Although it is less common, the halo sign may also be observed in nonhemorrhagic nodules, in which case either tumor cells or inflammatory infiltrate account for the halo of ground-glass attenuation.

Patient features

Several patient factors may influence the likelihood of a benign versus a malignant condition: these include previous exposure to smoke or other carcinogens such as asbestos, and previously diagnosed cancer or respiratory infections. A patient with airway symptoms, especially coughing up blood (hemoptysis), is more likely to have cancer compared to a patient with no respiratory symptoms.

Treatment

Recommendations for Follow-up and Management of Nodules <8 mm Detected Incidentally at Non-screening CT

Nodule Size (mm) Low risk patients High risk patients
Less than or equal to 4 No follow-up needed. Follow-up at 12 months. If no change, no further imaging needed.
>4 - 6 Follow-up at 12 months. If no change, no further imaging needed. Initial follow-up CT at 6 -12 months and then at 18 - 24 months if no change.
>6 - 8 Initial follow-up CT at 6 -12 months and then at 18 - 24 months if no change. Initial follow-up CT at 3 - 6 months and then at 9 -12 and 24 months if no change.
>8 Follow-up CTs at around 3, 9, and 24 months. Dynamic contrast enhanced CT, PET, and/or biopsy Same at for low risk patients

Note: Newly detected indeterminate nodule in persons 35 years of age or older.[1]

  • Low risk patients: Minimal or absent history of smoking and of other known risk factors.
  • High risk patients: History of smoking or of other known risk factors.

References


External Links

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools